RBC Capital rates Cardinal Health 'Outperform' after strong Q4 earnings and raised 2027 outlook.

RBC Capital initiated an 'Outperform' rating on Cardinal Health following the company's strong fiscal Q4 results, where adjusted EPS of $2.91 beat expectations by over 20%. Despite slightly lower sales than expected, high profitability and double-digit profit growth across all segments supported the positive outlook. Cardinal Health projects fiscal 2027 adjusted EPS between $12.40 and $12.60, above analyst consensus, and increased its share repurchase authorization by $5 billion to enhance shareholder value. This signals confidence in continued growth and strong market performance ahead.